[{"address1": "2001 Market Street", "address2": "Suite 3915 Unit #15", "city": "Philadelphia", "state": "PA", "zip": "19103", "country": "United States", "phone": "267 225 7416", "website": "https://www.contexttherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. The company was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.", "fullTimeEmployees": 12, "companyOfficers": [{"maxAge": 1, "name": "Mr. Martin A. Lehr", "age": 40, "title": "Co-Founder, President, CEO & Director", "yearBorn": 1984, "fiscalYear": 2024, "totalPay": 765596, "exercisedValue": 0, "unexercisedValue": 27676}, {"maxAge": 1, "name": "Ms. Jennifer  Minai-Azary", "age": 46, "title": "CFO & Treasurer", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 564090, "exercisedValue": 0, "unexercisedValue": 15208}, {"maxAge": 1, "name": "Mr. Alex C. Levit Esq., J.D.", "age": 45, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 541334, "exercisedValue": 0, "unexercisedValue": 14582}, {"maxAge": 1, "name": "Mr. Christopher  Beck M.B.A.", "title": "Senior Vice President of Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jeffrey  Liebman", "title": "Associate Director of Accounting", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jennifer  Dashnau M.B.A., Ph.D.", "title": "Senior Vice President of Technical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Karen  Chagin M.D.", "title": "Chief Medical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.14, "open": 1.14, "dayLow": 0.9999, "dayHigh": 1.14, "regularMarketPreviousClose": 1.14, "regularMarketOpen": 1.14, "regularMarketDayLow": 0.9999, "regularMarketDayHigh": 1.14, "payoutRatio": 0.0, "beta": 1.944, "forwardPE": -3.758621, "volume": 716130, "regularMarketVolume": 716130, "averageVolume": 300374, "averageVolume10days": 220880, "averageDailyVolume10Day": 220880, "bid": 0.8208, "ask": 1.28, "bidSize": 2, "askSize": 2, "marketCap": 100148304, "fiftyTwoWeekLow": 0.49, "fiftyTwoWeekHigh": 1.65, "allTimeHigh": 10.87, "allTimeLow": 0.47, "fiftyDayAverage": 1.12552, "twoHundredDayAverage": 0.850485, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 23350320, "profitMargins": 0.0, "floatShares": 51020507, "sharesOutstanding": 91879177, "sharesShort": 847576, "sharesShortPriorMonth": 493155, "sharesShortPreviousMonthDate": 1759190400, "dateShortInterest": 1761868800, "sharesPercentSharesOut": 0.0092, "heldPercentInsiders": 0.0227, "heldPercentInstitutions": 0.75361, "shortRatio": 1.71, "shortPercentOfFloat": 0.0111, "impliedSharesOutstanding": 91879177, "bookValue": 0.796, "priceToBook": 1.3693467, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -26440916, "trailingEps": -0.24, "forwardEps": -0.29, "enterpriseToEbitda": -0.773, "52WeekChange": -0.21917808, "SandP52WeekChange": 0.09209216, "quoteType": "EQUITY", "currentPrice": 1.09, "targetHighPrice": 9.0, "targetLowPrice": 4.0, "targetMeanPrice": 5.33333, "targetMedianPrice": 5.0, "recommendationMean": 1.375, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 76938184, "totalCashPerShare": 0.837, "ebitda": -30193288, "totalDebt": 140200, "quickRatio": 12.747, "currentRatio": 13.098, "debtToEquity": 0.192, "returnOnAssets": -0.22808, "returnOnEquity": -0.33675998, "freeCashflow": -14823796, "operatingCashflow": -22349156, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "CNTX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1763770539, "regularMarketTime": 1763758802, "exchange": "NCM", "messageBoardId": "finmb_408000800", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -4.38596, "regularMarketPrice": 1.09, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1634736600000, "postMarketChangePercent": 2.752291, "postMarketPrice": 1.12, "postMarketChange": 0.029999971, "regularMarketChange": -0.05, "regularMarketDayRange": "0.9999 - 1.14", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 300374, "fiftyTwoWeekLowChange": 0.6, "fiftyTwoWeekLowChangePercent": 1.2244898, "fiftyTwoWeekRange": "0.49 - 1.65", "fiftyTwoWeekHighChange": -0.55999994, "fiftyTwoWeekHighChangePercent": -0.3393939, "fiftyTwoWeekChangePercent": -21.917809, "earningsTimestampStart": 1746648597, "earningsTimestampEnd": 1746648597, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.24, "epsForward": -0.29, "epsCurrentYear": -0.35, "priceEpsCurrentYear": -3.114286, "fiftyDayAverageChange": -0.035519958, "fiftyDayAverageChangePercent": -0.031558707, "twoHundredDayAverageChange": 0.239515, "twoHundredDayAverageChangePercent": 0.28162166, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-10-20", "averageAnalystRating": "1.4 - Strong Buy", "shortName": "Context Therapeutics Inc.", "longName": "Context Therapeutics Inc.", "trailingPegRatio": null, "__fetch_time": "2025-11-22"}]